CTIS.eu › Cities › Finland › Tampere
Tampere
Finland
259 total trials
111 recruiting
2023-508922-83-00
10
2021-03-17
Advanced Non-Small Cell Lung Cancer
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
2022-501456-28-00
5
2020-07-20
atypical teratoid/rhabdoid tumours (ATRT)
2022-501050-11-01
10
2020-07-13
Acute Lymphoblastic Leukaemia
2022-501454-11-00
5
2020-02-05
standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
2024-517854-91-00
5
2019-08-05
Metastatic or high-risk recurrent prostate cancer managed with androge
2023-508101-24-00
5
2019-08-01
Lymphoblastic lymphoma
2022-501254-10-00
5
2018-08-24
Advanced tumors
2024-517488-22-00
6
2018-05-28
Patients in high risk for infantile spasm syndrome (age under 1 yr old
2024-517236-22-00
5
2017-09-20
Intradural saccular unruptured aneurysm
2023-506987-15-00
9
2016-11-17
Metastatic Castration-Resistant Prostate Cancer
2024-512222-28-00
10
2015-06-02
Newly diagnosed with an intracranial or spinal ependymoma (all WHO gra
2024-516078-31-00
10
2015-05-05
Recurrent and Primary Refractory Ewing Sarcoma
2024-518254-16-00
5
2013-03-01
Acute Myeloid Leukemia (Pediatric 0-18 years)
2024-519743-15-00
5
2025-10-20
Influenza immunisation
2025-520520-17-00
5
2025-09-05
Heterozygous familial hypercholesterolaemia
2024-517081-42-00
4
2025-08-15
Celiac Disease
2024-516814-39-00
5
2025-05-20
Chronic rhinosinusitis with nasal polyps
2024-512925-95-00
5
2025-05-16
Advanced/Metastatic Breast Cancer
2023-505601-16-00
5
2025-04-22
Chronic Migraine
2023-510465-10-00
4
2025-03-10
Meningococcal immunization
2024-510753-10-00
5
2024-11-01
Prurigo Nodularis
2023-508636-61-00
5
2024-10-24
Crohn’s Disease
2024-511213-38-00
4
2024-10-15
Coeliac disease
Showing 121–144 of 259 trials